These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9414989)

  • 1. Visceral analgesics and functional dyspepsia: have we found the Holy Grail?
    Talley NJ
    Gut; 1997 Nov; 41(5):717-8. PubMed ID: 9414989
    [No Abstract]   [Full Text] [Related]  

  • 2. Visceral analgesia: an emerging concept for managing functional gastrointestinal disease.
    Hasler WL
    Gastroenterology; 1998 Oct; 115(4):1023-4. PubMed ID: 9786728
    [No Abstract]   [Full Text] [Related]  

  • 3. Peripheral kappa-opioid agonists for visceral pain.
    Rivière PJ
    Br J Pharmacol; 2004 Apr; 141(8):1331-4. PubMed ID: 15051626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy: non-serotonergic mechanisms.
    Spiller R
    Gut; 2002 Jul; 51 Suppl 1(Suppl 1):i87-90. PubMed ID: 12077075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic modulation of visceral sensation: upper gastrointestinal tract.
    Tack J; Sarnelli G
    Gut; 2002 Jul; 51 Suppl 1(Suppl 1):i77-80. PubMed ID: 12077073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centrally acting agents and visceral sensitivity.
    Fioramonti J; Bueno L
    Gut; 2002 Jul; 51 Suppl 1(Suppl 1):i91-5. PubMed ID: 12077076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans.
    Delgado-Aros S; Chial HJ; Camilleri M; Szarka LA; Weber FT; Jacob J; Ferber I; McKinzie S; Burton DD; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G558-66. PubMed ID: 12631557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of functional dyspepsia.
    Thumshirn M
    Gut; 2002 Jul; 51 Suppl 1(Suppl 1):i63-6. PubMed ID: 12077069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kappa opioid receptor is associated with the perception of visceral pain.
    Black D; Trevethick M
    Gut; 1998 Sep; 43(3):312-3. PubMed ID: 9863470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium channel blocking actions of the kappa-opioid receptor agonist U50,488 contribute to its visceral antinociceptive effects.
    Su X; Joshi SK; Kardos S; Gebhart GF
    J Neurophysiol; 2002 Mar; 87(3):1271-9. PubMed ID: 11877501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a kappa-opioid agonist, i.v. JNJ-38488502, on sensation of colonic distensions in healthy male volunteers.
    Floyd BN; Camilleri M; Busciglio I; Sweetser S; Burton D; Wong GY; Kell S; Khanna S; Hwang S; Zinsmeister AR
    Neurogastroenterol Motil; 2009 Mar; 21(3):281-90. PubMed ID: 18823290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food and hypersensitivity in functional dyspepsia.
    Read NW
    Gut; 2002 Jul; 51 Suppl 1(Suppl 1):i50-3. PubMed ID: 12077065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia.
    Read NW; Abitbol JL; Bardhan KD; Whorwell PJ; Fraitag B
    Gut; 1997 Nov; 41(5):664-8. PubMed ID: 9414975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral perception in functional gastro-intestinal disorders: disease marker or epiphenomenon?
    Hu WH; Talley NJ
    Dig Dis; 1996; 14(5):276-88. PubMed ID: 8902414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs affecting visceral sensitivity: ready for the prime time?
    Delvaux MM; Gay G
    Dig Dis; 2006; 24(1-2):99-104. PubMed ID: 16699268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional dyspepsia: the role of visceral hypersensitivity in its pathogenesis.
    Keohane J; Quigley EM
    World J Gastroenterol; 2006 May; 12(17):2672-6. PubMed ID: 16718751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist and antagonist effects of dynorphin A-(1-13) in a thermal antinociception assay in rhesus monkeys.
    Butelman ER; France CP; Woods JH
    J Pharmacol Exp Ther; 1995 Oct; 275(1):374-80. PubMed ID: 7562573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of kappa-opioid receptors in visceral nociception in mice.
    Larsson MH; Bayati A; Lindström E; Larsson H
    Neurogastroenterol Motil; 2008 Oct; 20(10):1157-64. PubMed ID: 18643891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of fat and cholecystokinin in functional dyspepsia.
    Fried M; Feinle C
    Gut; 2002 Jul; 51 Suppl 1(Suppl 1):i54-7. PubMed ID: 12077066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement.
    Negus SS; Mello NK
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1132-40. PubMed ID: 10454487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.